CCM
EBAC

CAAS Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

CAAS Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$977K Hold
2022
Q3 		$958K Hold
2022
Q2 		$947K Buy
2022
Q1 		– Sell
2021
Q4 		$937K Hold
2021
Q3 		$935K Buy